Methods, devices, and compositions for measuring and inducing cell-to-cell communication, and therapeutic uses thereof

Patent metadata

Field	Value
Publication number	US-11833367-B2
Application number	US-201916599732-A
Country	US
Kind code	B2
Filing date	Oct 11, 2019
Priority date	Oct 12, 2018
Publication date	Dec 5, 2023
Grant date	Dec 5, 2023

Abstract

Methods of treating a subject are provided, involving providing a first region of biological material coupled to the subject; initiating a change in a cellular environment of the cells in the first region; and due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject, along with various biophoton collectors and biophoton bypasses useful for implementing a variety of the method embodiments.

First claim

The invention claimed is:

1. A method of triggering cell-to-cell communication in a subject comprising:
providing a first region of biological material coupled to the subject;
initiating a change in a cellular environment of the cells in the first region, wherein initiating a change comprises changing a rate of transport of reagents through cell membranes of cells in the biological material of the first region by changing a probability of tunneling of the reagents through cell membranes, wherein changing a probability of tunneling comprises applying a photon flux to the reagents to increase an energy of the reagents; and
due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject.

2. The method of claim 1 , further comprising defining for the first region a region inside the subject proximate the second region.

3. The method of claim 2 , wherein the region inside the subject is formed of the subject's own tissue.

4. The method of claim 2 , wherein the region inside the subject is biological material implanted inside the subject.

5. The method of claim 1 , further comprising defining for the first region a region inside the subject remote from the second region.

6. The method of claim 5 , wherein the region inside the subject is formed of the subject's own tissue.

7. The method of claim 5 , wherein the region inside the subject is biological material implanted inside the subject.

8. The method of claim 1 , further comprising defining for the first region a region inside the subject overlapping the second region.

9. The method of claim 1 , wherein providing comprises segregating the biological material of the first region from the second region by an artificial material.

10. The method of claim 9 , wherein the artificial material comprises a material capable of transmission of biophotons therethrough.

11. The method of claim 1 , wherein the first region and the second region are quantum entangled regions.

12. A method of triggering cell-to-cell communication in a subject comprising:
providing a first region of biological material coupled to the subject;
initiating a change in a cellular environment of the cells in the first region; and
due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject by coupling to the second region via interactions of DNA molecules along a pathway from the first region to the second region, where coupling comprises having the pathway comprise signaling DNA.

13. A method of triggering cell-to-cell communication in a subject comprising:
providing a first region of biological material coupled to the subject;
initiating a change in a cellular environment of the cells in the first region; and
due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject by coupling to the second region via interactions of DNA molecules along a pathway from the first region to the second region, where coupling comprises having the pathway comprise signaling DNA and transporting charge along the signaling DNA.

14. The method of claim 1 , wherein the biological change is a change in viability and wherein the change in the viability of the cells in the first region produces a similar change in the second region of the subject.

15. The method of claim 1 , wherein the biological change in the second region comprises a change in neuron activity.

16. The method of claim 15 , wherein the change in neuron activity is stimulation and/or control of neural communication.

17. The method of claim 12 , further comprising defining for the first region a region inside the subject proximate the second region.

18. The method of claim 17 , wherein the region inside the subject is formed of the subject's own tissue.

19. The method of claim 17 , wherein the region inside the subject is biological material implanted inside the subject.

20. The method of claim 12 , further comprising defining for the first region a region inside the subject remote from the second region.

21. The method of claim 20 , wherein the region inside the subject is formed of the subject's own tissue.

22. The method of claim 20 , wherein the region inside the subject is biological material implanted inside the subject.

23. The method of claim 12 , further comprising defining for the first region a region inside the subject overlapping the second region.

24. The method of claim 12 , wherein providing comprises segregating the biological material of the first region from the second region by an artificial material.

25. The method of claim 24 , wherein the artificial material comprises a material capable of transmission of biophotons therethrough.

26. The method of claim 12 , wherein the first region and the second region are quantum entangled regions.

27. The method of claim 12 , wherein the biological change is a change in viability and wherein the change in the viability of the cells in the first region produces a similar change in the second region of the subject.

28. The method of claim 12 , wherein the biological change in the second region comprises a change in neuron activity.

29. The method of claim 28 , wherein the change in neuron activity is stimulation and/or control of neural communication.

30. The method of claim 13 , further comprising defining for the first region a region inside the subject proximate the second region.

31. The method of claim 30 , wherein the region inside the subject is formed of the subject's own tissue.

32. The method of claim 30 , wherein the region inside the subject is biological material implanted inside the subject.

33. The method of claim 13 , further comprising defining for the first region a region inside the subject remote from the second region.

34. The method of claim 33 , wherein the region inside the subject is formed of the subject's own tissue.

35. The method of claim 33 , wherein the region inside the subject is biological material implanted inside the subject.

36. The method of claim 13 , further comprising defining for the first region a region inside the subject overlapping the second region.

37. The method of claim 13 , wherein providing comprises segregating the biological material of the first region from the second region by an artificial material.

38. The method of claim 37 , wherein the artificial material comprises a material capable of transmission of biophotons therethrough.

39. The method of claim 13 , wherein the first region and the second region are quantum entangled regions.

40. The method of claim 13 , wherein the biological change is a change in viability and wherein the change in the viability of the cells in the first region produces a similar change in the second region of the subject.

41. The method of claim 13 , wherein the biological change in the second region comprises a change in neuron activity.

42. The method of claim 41 , wherein the change in neuron activity is stimul

Assignees

• Immunolight Llc

Inventors

• Bourke Jr Frederic A
• Walder Harold
• Fathi Zakaryae
• Beyer Jr Wayne F
• Rudder Ronald A

Classifications

• A61N2005/0661

  ultraviolet · CPC title

• A61N2005/0659

  infrared · CPC title

• A61M2037/0007

  having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents · CPC title

• A61N2/02

  using magnetic fields produced by coils, including single turn loops or electromagnets (A61N2/12 takes precedence) · CPC title

• A61N5/025

  Warming the body, e.g. hyperthermia treatment · CPC title